Mylotarg Recalled Due to Health Risks
A recent article stated that the cancer drug, Mylotarg, will be recalled due to new studies revealing that it has a higher rate of deadly health risks and a low amount of health benefits. The drug was originally released in the year 2000 in order to help cancer patients who were not responding well to chemotherapy.
According to the FDA, the drug went through several new clinical trials in which it was determined that the drug did not appear to work and that patients taking the drug had a higher rate of death than those patients on chemotherapy. Regulators apparently knew of the connection of the drug to veno-occlusive disease – a life threatening liver condition – but underestimated the high rate of occurrence that the condition had in patients using the drug. In light of this new discovery, the drug is being recalled.
Mylotarg has been deemed a defective drug and will be removed from the market due to the serious, sometimes fatal, injuries it has caused. Pharmaceutical companies responsible for designing, manufacturing and marketing drugs that are dangerous or defective may be held accountable for failing to properly warn customers about the risks of the medicine.
If you or someone you love has been seriously injured or wrongfully killed by medication that has been recalled and deemed dangerous, please call one of the experienced San Fernando Valley pharmaceutical litigation attorneys at The Mandell Law Firm today for a free consultation. Our attorneys have years of experience dealing with pharmaceutical and personal injury litigation and will be able to help. We can assist you in obtaining compensation to pay for steep medical expenses, rehabilitation, therapy, and loss of income. Call The Mandell Law Firm today at 818-886-6600 for a free consultation and to learn more about how we can help.
